SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

GBTC is trending as Bitcoin flirts with all-time highs, driving discussion about potential breakouts and future price targets. Community members are closely watching technical indicators and whale activity, anticipating a continued uptrend. Broader market factors, like potential shifts from gold to Bitcoin and the impact of government policies, are also being considered.

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat is gaining attention, with community members highlighting its recent launch on Phantom Wallet and potential for significant growth. The conversation revolves around 'moon' and 'rocket' references suggesting possible rapid price appreciation. Some users are pointing out potential scam risks.

Moo Deng

MOODENG is trending as traders discuss recent price volatility and potential for a breakout. Community members are debating entry points, with some pointing to technical analysis patterns, while others express skepticism, citing its meme coin status and past performance. The coin's listing on Robinhood and upcoming birthday are also being mentioned as potential catalysts.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending following FDA approval of their leukemia drug, Revuforj, though a boxed warning regarding potentially fatal side effects tempers initial enthusiasm. The community is debating the impact of the safety label, comparing it to competitor Kura Oncology's profile, and weighing whether the market is overreacting given the drug's efficacy and the unmet need it addresses. Some believe the dip is a buying opportunity, while others worry about potential risks and side effects.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending as investors anticipate potential new contracts following its Gen AI Summit, where over 300 AI executives were in attendance. The community speculates about a possible TikTok deal and expansion into government contracts, driving institutional interest. Bullish sentiment is fueled by analysts increasing price targets, though some caution against excessive speculation and highlight the company's AI-driven growth amid rising competition.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as the stock price continues to drop post FDA approval, leading to discussions around management, dilution, and future prospects. The community is debating whether the current price represents a buying opportunity or reflects deeper issues with the company's leadership and commercialization strategy. Some traders are noting potential short squeeze setups due to high short interest.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid discussions about a potential recall of specific lots and the impact on revenue, with community members analyzing the company's response and comparing it to similar situations with competitors. Some traders are interpreting recent stock sales by the CEO, alongside an FDA safety notice, while others suggest potential manufacturing issues. Despite concerns, many community members express confidence in the company's long-term growth and potential for a buyback.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is trending as investors discuss dividend payouts, NAV erosion, and overall profitability; some express concern over the fund's long-term viability. Community members are weighing strategies like reinvesting dividends versus taking profits, with some considering alternative high-yield ETFs.  Broader discussions include the impact of market volatility and potential reverse splits.

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Inhibrx Biosciences Inc.

Inhibrx Inc

Inhibrx ($INBX) is trending due to positive updates on its INBRX-101 drug for AATD, specifically regarding a functional alpha-1 antitrypsin serum levels endpoint, leading to speculation about accelerated FDA approval; the community is actively discussing its potential and analyst target price increase. Some traders are noting its low float and potential for a short squeeze, while others are wary of a possible upcoming offering.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to advancements in quantum computing, including a partnership leveraging AMD chips for error correction, which has driven its largest single-day stock surge since January; community discussions highlight IBM's potential leadership in quantum and AI. While reactions to recent earnings have been mixed, some see the stock as undervalued, with potential upside driven by its hybrid cloud and AI initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

123-year-old mall anchor faces Chapter 11 bankruptcy risk

One of the United States oldest retailers has struggled to pay its bills.The chain has been slow to pay vendors, which puts its holiday inventory at risk.The company has not commented on a potential...

Ross Stores thrives with major expansion plans while retail giants close locations nationwide

Ross Stores Inc. announced plans to expand its footprint at a time when much of the retail industry is contracting in an effort to stay profitable. The California-based bargain retail chain recently...

How homeowners can earn rewards points for paying their mortgage

Homeowners will soon have the chance to start earning rewards points for paying off their mortgage every month. Bilt, a loyalty program designed to help members utilize their largest expenses for...

Amazon takes another shot at fixing a huge health care problem

Amazon wants to help fix the American health care system, but it has learned that actually doing so is really difficult.The company has failed multiple times, but that has not stopped it from trying...

Amazon to solve a growing customer problem with vending machines

Access to affordable medication is becoming an increasingly urgent issue across the nation. Millions of Americans live far away from a pharmacy, and most of those who are in remote areas have lower...

U.S. stocks shrugged off the early indecision seen on Wednesday, following the release of mixed economic data, and ended higher. The S&amp;P 500 Index picked up enough momentum to close at a new record. The see-sawing mood will likely continue in the coming sessions, at least until the release of the August non-farm payrolls report.&nbsp;Company-specific catalysts, including earnings news and changes in index constituents, led to heightened activity in the following stocks in the after-hours session.&nbsp;Walgreens Boots Alliance, Inc. (WBA)After-hours move: +0.50%Trading volume: 93.18 millionThe substantial after-hours volume in&nbsp;<a href="https://stocktwits.com/symbol/WBA">Walgreens Boots Alliance stock</a> occurred as the company is set to be removed from the S&amp;P 500 Index, effective before the market opens on Thursday, following the retail pharmacy chain's agreement to be taken private by Sycamore Partners in a deal valued at $23.7 billion.WBA shareholders will receive total consideration consisting of $11.45 per share in cash at closing of the Sycamore transaction and one non-transferable right to receive up to $3 in cash per WBA share from the future monetization of WBA’s debt and equity interests in VillageMD.The stock was halted for trading after the close of trading on Wednesday, and will remain suspended until it is delisted.On Stocktwits, retail sentiment toward WBA stock remained ‘bullish’ (75/100) by late Wednesday, and the message volume on the stream was ‘extremely high.’<figure class="image"><img style="aspect-ratio:616/57;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_28_at_12_30_10_AM_png_03e19e4316.webp" alt="Screenshot 2025-08-28 at 12.30.10 AM.png" width="616" height="57"><figcaption>WBA sentiment and message volume as of 12:25 a.m. ET, Aug. 28 | source: Stocktwits</figcaption></figure>The stock has gained 28.40% year-to-date (YTD).Interactive Brokers Group, Inc. (IBKR)After-hours move: +0.10%Trading volume: 60.76 millionShares of Interactive Brokers gained steam as they are set to be added to the S&amp;P 500 Index ahead of Thursday’s market open, replacing WBA in the broader gauge.&nbsp;<a href="https://stocktwits.com/symbol/IBKR">Interactive Brokers’ stock</a> rose 0.9% on Thursday after S&amp;P Dow Jones Indices’ announcement in this regard, but fell over 2% on Wednesday.Retail sentiment toward the stock remained ‘extremely bullish’ (92/100) among Stocktwits users, with the message volume at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:620/55;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_28_at_12_28_46_AM_png_90b6a00a02.webp" alt="Screenshot 2025-08-28 at 12.28.46 AM.png" width="620" height="55"><figcaption>IBKR &nbsp;sentiment and message volume as of 12:25 a.m. ET, Aug. 28 | source: Stocktwits</figcaption></figure>YTD, Interactive Brokers’ stock has soared over 40%.Nvidia Corp. (NVDA)After-hours move: -3.10%Trading volume: 59.72 millionNvidia’s stock remained on investors’ radar after the artificial intelligence (AI) chip giant reported forecast-beating results for the second quarter of fiscal year 2026. The stock, however, slid more than 3% in after-hours trading as investors expressed disappointment over the slight data center sales miss and the deceleration in sales growth the company forecasted for the third quarter.Retail traders’ optimism abounded, with the sentiment meter on Stocktwits reading 93/100, suggesting an ‘extremely bullish’ mood, up from the ‘bullish’ sentiment seen a day ago. The message volume also picked up pace to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:616/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_28_at_12_27_52_AM_png_e393e19592.webp" alt="Screenshot 2025-08-28 at 12.27.52 AM.png" width="616" height="63"><figcaption>NVDA sentiment and message volume as of 12:25 a.m. ET, Aug. 28 | source: Stocktwits</figcaption></figure>Nvidia’s stock is up 35.25% this year.Lucid Group, Inc. (LCID)After-hours move: unchangedTrading volume: 13.89 millionThe increased interest in luxury electric-vehicle (EV) maker&nbsp;<a href="https://stocktwits.com/symbol/LCID">Lucid’s stock</a> comes as a 1-for-10 reverse stock split announced by the company takes effect on Friday. The stock will begin trading on a reverse split-adjusted basis on Tuesday.&nbsp;On Stocktwits, retail sentiment toward the stock remained ‘bullish’ (57/100) and the message volume was ‘normal.’<figure class="image"><img style="aspect-ratio:620/51;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_28_at_12_26_53_AM_png_e8c30d675c.webp" alt="Screenshot 2025-08-28 at 12.26.53 AM.png" width="620" height="51"><figcaption>LCID sentiment and message volume as of 12:25 a.m. ET, Aug. 28 | source: Stocktwits</figcaption></figure>The stock has declined&nbsp;by more than 31% this year, amid worsening EV market fundamentals and the company’s production woes.Intel Corp. (INTC)After-hours move: -0.38%Trading volume: 8.57 millionShares of Intel resumed their climb on Wednesday, snapping a two-day losing streak, as investors remained interested in the stock amid the U.S. government’s move to invest in the company.<a href="https://stocktwits.com/symbol/INTC">Intel stock</a> elicited ‘bullish’ sentiment (69/100) from among retailers on the Stocktwits platform, with the buoyant mood accompanied by ‘high’ message volume.<figure class="image"><img style="aspect-ratio:615/51;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_28_at_12_25_03_AM_png_d5c3d0531f.webp" alt="Screenshot 2025-08-28 at 12.25.03 AM.png" width="615" height="51"><figcaption>INTC sentiment and message volume as of 12:25 a.m. ET, Aug. 28 | source: Stocktwits</figcaption></figure>YTD, the chipmaker’s stock has added nearly 24%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-stock-is-clear-buying-opportunity-analysts-laud-q2-print-outlook-despite-china-worries/chsCuP6Rdlj">Nvidia Stock Is ‘Clear Buying Opportunity’ — Analysts Laud Q2 Print, Outlook Despite China Worries</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on July 11, 2025 in New York City. As new tariffs continue to concern investors, the Dow fell over 250 points in trading Friday. 

Walgreens Boots, Interactive Brokers, Nvidia, Lucid, Intel: What Sparked Heavy After-Hours Trading In These 5 Stocks?

Company-specific catalysts, including earnings news and changes in index constituents, led to heightened activity in some stocks in Wednesday’s after-hours session.

Equity

Company-specific catalysts, including earnings news and changes in index constituents, led to heightened activity in some stocks in Wednesday’s after-hours session.


Alpha Modus Holdings (AMOD), a retail technology company, announced on Thursday that it has reached a settlement in its in-store technology patent infringement lawsuit against Walgreens Co. (WBA).The terms of the settlement are confidential, and the lawsuit will be dismissed with prejudice, Alpha Modus said. The case was filed in the United States District Court for the Eastern District of Texas and involved claims related to Alpha Modus’s U.S. Patent.&nbsp;Retail sentiment on <a href="https://stocktwits.com/symbol/WBA">Walgreens</a> improved to ‘neutral’ from ‘bullish’ territory, with chatter at ‘normal’ levels, according to Stocktwits data. Shares of the company were down marginally on Thursday morning.&nbsp;In February, Alpha Modus filed the patent infringement lawsuit that also alleges willful infringement against Walgreens. The company said Walgreens allegedly willfully infringed on Alpha Modus’s patented AI-driven retail technology, which enhances in-store shopping through data-driven insights, interactive advertising, and consumer engagement tools.&nbsp;Walgreens’ deployment of digital smart screens known as “Cooler Screens” mirrors the innovations protected under Alpha Modus’s patents, necessitating this legal action, Alpha Modus had noted in February.&nbsp;On Thursday, Alpha Modus CEO William Alessi said that the company appreciates the opportunity to amicably resolve this matter in a timely and effective manner. “This outcome reflects our continued commitment to safeguarding the value of our intellectual property while promoting constructive relationships across the retail and technology sectors,” Alessi added.Alpha Modus said it has now resolved multiple enforcement actions as part of its broader intellectual property monetization strategy and continues to pursue licensing and litigation opportunities involving its patented technologies.Walgreens’ stock has gained nearly 31% so far this year and jumped over 21% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/instacart-gets-a-wedbush-downgrade-on-rising-pressure-from-amazon-s-same-day-grocery-push/chsSyZ8RdiW">Instacart Gets A Wedbush Downgrade On Rising Pressure from Amazon’s Same-Day Grocery Push, Retail Maintains Its Pessimistic Stance</a>

Walgreens store is seen in Chicago, United States, on October 17, 2022. (Photo by Beata Zawrzel/NurPhoto via Getty Images)

Alpha Modus Settles Patent Infringement Lawsuit Against Walgreens

Alpha Modus said the terms of the settlement are confidential, and the lawsuit will be dismissed with prejudice.

Walgreens Boots Alliance (WBA) said on Friday that the struggling drug retailer’s shareholders approved its $10 billion buyout by New York-based private equity firm Sycamore Partners Management during a special meeting.<a href="https://stocktwits.com/symbol/WBA">Walgreens stock</a> fell marginally in midday trading. Retail sentiment around the stock improved to ‘neutral’ from the ‘bearish’ territory a day ago, according to data from Stocktwits.According to the preliminary results, about 96% of votes cast at the special meeting by all shareholders voted in favor of the merger agreement proposal, Walgreens added.“With Sycamore’s partnership, we will be better positioned to accelerate our turnaround strategy, further enhance the customer, patient, and team member experience, and become the first choice for pharmacy, retail, and health services. We look forward to closing the transaction and entering this next chapter,” Walgreens CEO Tim Wentworth said.Walgreens has faced weakening demand amid strategic restructuring and shifting consumer habits. Foot traffic declined in late 2024, partly offset by a shift in visits to fewer, more efficient stores, as the company planned to shutter 1,200 locations by 2027. Its healthcare push via VillageMD also underperformed, with an underfilled patient panel.The company’s shareholders are set to receive $11.45 per share in cash upon the completion of the Sycamore transaction. An additional $3 per share in value is expected through the future monetization of the company’s debt and equity holdings in its primary-care businesses, including Village Medical, Summit Health, and CityMD.Walgreens expects to close the transaction in the third or fourth quarter of calendar year 2025, subject to customary closing conditions, including the receipt of required regulatory approvals.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See:<a href="https://stocktwits.com/news-articles/markets/equity/levi-stock-surges-after-analysts-raise-price-target-on-stock-retail-sentiment-extremely-bullish/ch8cXLQR5ZF">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/louis-vuitton-uk-reports-cyberattack-resulting-in-customer-data-theft/ch8ch7zR5Zu">Louis Vuitton UK Reports Cyberattack Resulting in Customer Data Theft: Report</a>

Walgreens Pharmacy sign mounted on stone facade, San Francisco, California, May 13, 2025. 

Walgreens Shareholders Approve $10 Billion Take-Private Offer By Sycamore Partners

According to preliminary results, Walgreens stated that approximately 96% of votes cast at the special meeting by all shareholders voted in favor of the merger agreement proposal.

Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?

Strong pharmacy drug mix, flu season and store optimization power CVS Health's PCW gains. Will the momentum continue?

Company News for Jun 27, 2025

Companies in The News Are: WBA,MKC,AYI,LNN

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Walgreens Boots Alliance Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

WBA
Walgreens Boots Alliance Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest WBA News

WBAWalgreens Boots Alliance Inc